PT. Penta Valent Tbk (IDX:PEVE)

Market Cap	589.72B
Revenue (ttm)	3.14T
Net Income (ttm)	52.48B
Shares Out	1.77B
EPS (ttm)	30.22
PE Ratio	11.05
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	480,500
Average Volume	272,905
Open	328.00
Previous Close	330.00
Day's Range	318.00 - 338.00
52-Week Range	218.00 - 370.00
Beta	0.12
RSI	54.34
Earnings Date	Jul 30, 2025

About PT. Penta Valent Tbk

PT. Penta Valent Tbk distributes pharmaceutical products, medical equipment, and consumer products in Indonesia. It operates through Pharmaceutical Products and Consumer Goods segments. The company offers medicinal products; over the counter drug products; medical supporting equipment, such as blood pressure meters, body thermometers, and others; reaction materials, such as blood sugar tests, pregnancy tests, or rapid tests for Covid-19, drug tests, etc.; and food supplements comprising minerals and nutrients. It also provides products for beau...

• Industry: Pharmaceutical Retailers
• Sector: Healthcare
• Founded: 1968
• Employees: 971
• Stock Exchange: Indonesia Stock Exchange
• Ticker Symbol: PEVE

Financial Performance

In 2024, PT. Penta Valent Tbk's revenue was 3.01 trillion, an increase of 21.25% compared to the previous year's 2.48 trillion. Earnings were 48.01 billion, an increase of 32.73%.